Heart Failure: Diagnosis, Management and Utilization
Despite the advancement in medicine, management of heart failure (HF), which usually presents as a disease syndrome, has been a challenge to healthcare providers. This is reflected by the relatively higher rate of readmissions along with increased mortality and morbidity associated with HF. In this...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
MDPI
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961993/ |
| id |
pubmed-4961993 |
|---|---|
| recordtype |
oai_dc |
| spelling |
pubmed-49619932016-08-01 Heart Failure: Diagnosis, Management and Utilization Inamdar, Arati A. Inamdar, Ajinkya C. Review Despite the advancement in medicine, management of heart failure (HF), which usually presents as a disease syndrome, has been a challenge to healthcare providers. This is reflected by the relatively higher rate of readmissions along with increased mortality and morbidity associated with HF. In this review article, we first provide a general overview of types of HF pathogenesis and diagnostic features of HF including the crucial role of exercise in determining the severity of heart failure, the efficacy of therapeutic strategies and the morbidity/mortality of HF. We then discuss the quality control measures to prevent the growing readmission rates for HF. We also attempt to elucidate published and ongoing clinical trials for HF in an effort to evaluate the standard and novel therapeutic approaches, including stem cell and gene therapies, to reduce the morbidity and mortality. Finally, we discuss the appropriate utilization/documentation and medical coding based on the severity of the HF alone and with minor and major co-morbidities. We consider that this review provides an extensive overview of the HF in terms of disease pathophysiology, management and documentation for the general readers, as well as for the clinicians/physicians/hospitalists. MDPI 2016-06-29 /pmc/articles/PMC4961993/ /pubmed/27367736 http://dx.doi.org/10.3390/jcm5070062 Text en © 2016 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/). |
| repository_type |
Open Access Journal |
| institution_category |
Foreign Institution |
| institution |
US National Center for Biotechnology Information |
| building |
NCBI PubMed |
| collection |
Online Access |
| language |
English |
| format |
Online |
| author |
Inamdar, Arati A. Inamdar, Ajinkya C. |
| spellingShingle |
Inamdar, Arati A. Inamdar, Ajinkya C. Heart Failure: Diagnosis, Management and Utilization |
| author_facet |
Inamdar, Arati A. Inamdar, Ajinkya C. |
| author_sort |
Inamdar, Arati A. |
| title |
Heart Failure: Diagnosis, Management and Utilization |
| title_short |
Heart Failure: Diagnosis, Management and Utilization |
| title_full |
Heart Failure: Diagnosis, Management and Utilization |
| title_fullStr |
Heart Failure: Diagnosis, Management and Utilization |
| title_full_unstemmed |
Heart Failure: Diagnosis, Management and Utilization |
| title_sort |
heart failure: diagnosis, management and utilization |
| description |
Despite the advancement in medicine, management of heart failure (HF), which usually presents as a disease syndrome, has been a challenge to healthcare providers. This is reflected by the relatively higher rate of readmissions along with increased mortality and morbidity associated with HF. In this review article, we first provide a general overview of types of HF pathogenesis and diagnostic features of HF including the crucial role of exercise in determining the severity of heart failure, the efficacy of therapeutic strategies and the morbidity/mortality of HF. We then discuss the quality control measures to prevent the growing readmission rates for HF. We also attempt to elucidate published and ongoing clinical trials for HF in an effort to evaluate the standard and novel therapeutic approaches, including stem cell and gene therapies, to reduce the morbidity and mortality. Finally, we discuss the appropriate utilization/documentation and medical coding based on the severity of the HF alone and with minor and major co-morbidities. We consider that this review provides an extensive overview of the HF in terms of disease pathophysiology, management and documentation for the general readers, as well as for the clinicians/physicians/hospitalists. |
| publisher |
MDPI |
| publishDate |
2016 |
| url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961993/ |
| _version_ |
1613615565094518784 |